| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $364K | +14.4% | +1358.0% |
| SG&A Expense | $990K | +35.0% | +361.5% |
| Operating Income | -$1.4M | -28.8% | -465.5% |
| Net Income | -$1.5M | -25.2% | -281.8% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $105K | -76.9% | -8.6% |
| Total Assets | $105K | -76.9% | -8.6% |
| Current Liabilities | $15.7M | +8.0% | +22.4% |
| Stockholders' Equity | -$15.6M | -10.7% | -22.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$675K | — | — |
| Financing Cash Flow | $691K | — | — |